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Background: Hypertension is a chronic disease that is considered to be a public health problem and requires efforts by patients
to manage themselves. The global growth in the use of mobile phones and tablets has been accompanied by the increased use of
health apps. Many of these apps support the self-management of hypertension and, therefore, they have the potential benefits of
lowering blood pressure. Despite this, there is currently a lack of evidence for their effectiveness, usability, and patient satisfaction
with their use.
Objective: A systematic review was conducted to assess the effectiveness of apps in lowering blood pressure, as well as their
usability and patients’ satisfaction with their use.
Methods: We conducted searches in the following databases: MEDLINE (OVID), EMBASE (OVID), PsycINFO (OVID),
CINAHL, the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), IEEE Xplore ASSIAN, Google
Scholar and the main Arabic databases Al Manhal, AskZad, and Mandumah. We looked for studies that used apps in the
self-management of hypertension from 2008-2016. We also checked the reference lists of the review papers and all the primary
studies for additional references.
Results: A total of 21 studies with a total of 3112 participants were included in the review. Of the 14 studies that assessed the
effectiveness of the apps in lowering blood pressure, 10 (71.4%) studies (6 RCTs and 4 nonrandomized studies) reported that
using the apps led to significant decreases in blood pressure and seemed to be effective in the self-management of hypertension.
Of these 10, only 2 (20%) RCTs and 3 (30%) nonrandomized studies had a low–moderate risk of bias. The results of this review
are inconclusive regarding which combinations of functionalities would be most effective in lowering blood pressure because of
variation in the studies’ quality, but the data suggest that apps incorporating more comprehensive functionalities are likely to be
more effective. In all the studies that assessed the usability of the apps and users’ acceptance of them, all the apps seemed to be
accepted and easy to use.
Conclusions: Most of the studies reported that apps might be effective in lowering blood pressure and are accepted by users.
However, these findings should be interpreted with caution, as most of the studies had a high risk of bias. More well-designed,
large-scale studies are required to evaluate the real effect of using apps in lowering blood pressure and to identify the most effective
functionality combinations for lowering blood pressure.
(JMIR Mhealth Uhealth 2018;6(7):e10723)   doi:10.2196/10723
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Hypertension, in which the blood pressure (BP) in the arteries
is raised, is one of the most common chronic diseases in adults.
Patients can be diagnosed with hypertension when their systolic
blood pressure (SBP) and diastolic blood pressure (DBP) are
above 140/90 mm Hg, respectively [1]. Hypertension has been
recognized as a major risk factor for many diseases, such as
renal failure, heart disease, and stroke [1]. Despite the effect of
lowering BP on reducing the risk of renal and cardiovascular
disease, most people with hypertension poorly control their BP
[2]. Therefore, it is important to encourage patients’ involvement
in controlling their BP.
Self-management is considered an important element of chronic
care management [3]. Self-management demands an active role
of patients in managing their symptoms, treatment, psychosocial
and physical effects, and changing lifestyle [4-6]. Achieving an
optimum level of self-management behavior is difficult and
requires considerable effort from patients. Mobile health
technology (mHealth), defined as the use of mobile devices to
deliver health care [7], has the potential to facilitate and optimize
patients’ self-management [8-11]. This can be performed by
integrating health care with everyday life by delivering and
collecting health information and services in a convenient,
accessible, and interactive mode [12,13]. The use of the new
generation of these mobile devices, including mobile phone and
tablets, has increased rapidly in recent years, and it is estimated
that by 2018 mobile phones will be used by one-third of the
global population [14]. Mobile phones have become an
important platform to deliver health to patients through health
apps. The rapid growth in the use of these devices has been
accompanied by a huge expansion in health and health-related
behavior apps, and more than 100,000 of these are used by
millions of people [14,15]. Many health apps are targeted to
support people with hypertension in their self-management by
offering self-monitoring activities, reminders, tailored
information, and feedback [16,17].
To the best of our knowledge, despite the potential benefits of
apps for people with hypertension and the increased use of these
apps, a synthesis of studies on their effectiveness in this
population has not been conducted. This systematic review will
synthesize the existing evidence on the effectiveness of apps in
lowering BP, as well as their usability and patients’ satisfaction
with their use.
Methods
A systematic review was conducted and reported per the
PRISMA statement for systematic reviews [18,19].
Eligibility Criteria
The inclusion criteria were dependent on PICOS [18] as
described below:
Population
The population was people with hypertension (18 years of age
and over) and health care professionals (HCPs) supporting
people with hypertension in their self-management in any care
setting, without limitations on the participants’ gender, age or
socio-demographic characteristics. Studies about people with
chronic illness including hypertension as one of their inclusion
criteria were also included.
Intervention
The intervention was a mobile phone or a tablet app that collects
data, provides feedback, connects with HCPs or informs about
hypertension to support the self-management tasks of
hypertension. These tasks include self-monitoring of BP and
other biometrics, healthy eating and drinking, being physically
active, maintaining a healthy weight, adhering to medication,
and managing stress and coping [1]. The app should also enable
interactions between the user and the device via a set of
interfaces (eg, a visual user interface). Studies in which a health
app was the only method of delivery or in which it was a
component of a blended intervention were also included.
Comparator
The comparator was either usual care or any other control
intervention. Articles with no comparison were also included.
Outcomes
The outcomes of studies that were considered are: levels of BP,
SBP, and DBP, as well as usability, attitudes, and satisfaction
with mobile apps.
Study Designs
The eligible study designs were all quantitative, qualitative, and
mixed-method studies that explore the self-management of
hypertension using apps. Pilot studies were included because
they might enable us to understand the status of apps.
Data Sources and Search Methods
The electronic databases EMBASE (OVID), MEDLINE
(OVID), PsycINFO (OVID), the Cochrane Central Register of
Controlled Trials (CENTRAL, The Cochrane Library), CINAH,
ASSIAN, and IEEE Xplore were searched, as was Google
Scholar. Hand searching through the reference lists of included
studies and systematic reviews was also conducted to find more
related studies. These databases were searched using the
concepts of hypertension, mobile apps, telemonitoring, and
self-management (see Multimedia Appendix 2 for the
MEDLINE search strategy). The search strategy was limited to
English research published from 2008, when the first app store
was launched, [12] to June 25, 2017.
Exclusion Criteria
Studies were excluded based on the criteria in Textbox 1.
Conference abstracts, protocols, commentaries or editorials or
studies not in English or Arabic were not included.
Study Selection
Reference management software (Endnote) was utilized to
collect results from databases, and to de-duplicate articles. Two
reviewers (TA and SA) independently scanned titles against the
eligibility criteria and in a second phase the abstracts of selected
titles. Cohen kappa was calculated to determine the agreement
between the reviewers for each step of selecting titles and
abstracts.
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Textbox 1. Exclusion criteria.
1. They were not aimed at hypertension or studies focusing only on primary prevention of hypertension or hypertension during pregnancy.
2. They examined interventions accessed by a personal digital assistant, desktop computer, laptop, netbook
3. They examined interventions accessed by a mobile phone or traditional tablet that did not permit participants to download or use any app from
the app store.
4. They solely used messaging including short message service (SMS) text messaging, multimedia messaging service (MMS), websites, calls, emails
or Web-based apps.
5. A mobile device was used to transmit information provided by a blood pressure monitoring device to care providers or clinicians, but in which
there was no interaction with the user.
6. They describe only the technological development of a mobile system.
Titles and in the second phase abstracts received 2 points if they
met the criteria, zero if not and 1 point when there was doubt.
If the sum of reviewer scores for a title was 2 or more, the study
was included for the next phase. Otherwise, it was excluded.
Two reviewers separately reviewed the full articles when the
total scores for the abstract equaled 2 points or more. Any
disagreements were resolved through a discussion with other
researchers (LdW and MSH).
Data Extraction and Quality Assessment
Two reviewers independently (TA and SA) extracted data and
assessed the quality of the included studies. Any disagreement
was resolved through a discussion with other researchers (LdW
and MSH) until consensus was reached.
Data were extracted using a standardized form, which was
piloted by the reviewers. The Cochrane Collaboration’s Risk
of Bias Tool was utilized to assess randomized controlled trials
(RCTs) [20]. Nonrandomized quantitative studies were evaluated
using 3 tools provided by the US National Institute of Health
(NIH), March 2014 version: 1 for observational studies, 1 for
controlled studies, and 1 for pre-post studies without control
group [21]. The Critical Appraisal Skills Programme (CASP)
was utilized for the quality assessment of qualitative studies
[22].
Data Synthesis and Analysis
An overview of the basic characteristics of the studies, including
the intervention, population, and outcome, was summarized in
a table. Data were not combined because of differences in the
designs of the studies. A narrative synthesis was conducted
instead [18,23]. All research findings were classified according
to review objectives.
Results
Summary of Search Results
The review steps are summarized in Figure 1. Searching the
electronic databases yielded a total of 6302 titles. After all
duplicates were removed, 5676 records remained for title
screening. Cohen kappa for agreement between the 2 reviewers
was 0.72. Subsequently, the 2 reviewers (TA and SA) assessed
the remaining 1968 abstracts; Cohen kappa for agreement
between them in that step was 0.83. Of these, 569 went forward
for full-text assessment, supplemented by 3 studies identified
from reference tracking. A total of 548 papers were excluded
at full-text screening, as they did not meet the criteria relating
to the participants or interventions, or they were conference
abstracts, editorials, or protocols. This led to a selection of 24
publications. Only 21of these were included in this review, as
2 publications were a subset analysis of a previous publication,
and 1 publication was about a part of the sample of a larger
study described in another publication.
Study Characteristics
There were 21 studies included in this review. The publication
year of the studies ranged from 2012 to 2017 (see Multimedia
Appendix 1). Most studies (11/21, 52%) were conducted in the
US [24-32] and Canada [33,34], while 7 (33.3%) were carried
out in European countries, including France [35], Sweden
[36-38], Spain [39,40] and Italy [41]. The remaining 3 (14.3%)
studies were conducted in China [42,43] and South Korea [44].
Of the 21 studies, 9 (43%) were randomized controlled trials
(RCTs) [24,25,27,28,30,33-35,42], 10 (48%) were
nonrandomized studies [26,29,31,32,37,39-41,43,44], and 2
(10%) were qualitative studies [36,38].
Fourteen (14/21, 67%) studies reported on the apps’
effectiveness in controlling BP. Of these studies, 4 (27%) also
assessed user satisfaction and experience with the apps
[27,30,31,39]. The remaining 7 (33%) studies that did not report
efficacy focused on user satisfaction with and attitudes towards
the apps and their usability [26,32,36,38,40,43,44]. The study
duration ranged from 1-12 months. The studies included a range
of 19 to 1012 participants, with a total of 3112 participants.
Participants’ mean age ranged from 42.4 [27] to 69.5 [42] years
of age. The population groups of the studies included individuals
with hypertension [24-30,32,36-39,41-44], metabolic syndrome
risk factors [34], obstructive sleep apnea with high
cardiovascular risk [35], and overweight individuals [31]. Of
the 21 included studies, 5 (24%) reported to having used
behavioral theories, such as self-determination theory [24,26,27],
motivational interviewing [30] and theory of planned behavior
[43] to underpin and guide the intervention methods and the
development of the technology. The other studies did not report
using behavioral theories. However, an investigation of the
apps’ functionalities identified recognizable elements of
behavioral strategies.
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Figure 1. PRISMA flow diagram.
All the included studies focused on supporting self-management
of hypertension. Nine (43%) of the included studies were aimed
to enhance self-management without involving clinicians to
monitor patients remotely [29,33,35-38,42-44]. The other 11
(52%) studies mainly involved clinicians or other HCPs remotely
monitoring patient data and health status [24-28,30-32,39-41],
while the remaining study involved the researcher remotely
monitoring patient data and alerting physicians if needed [34,36].
In these 11 (52%) studies involving HCPs, the HCPs provided
feedback, including a medication plan or adjustments
[24-27,39,41], regular online coaching consultation, [31]
instructions [28,30], or communication with patients [40,42]
(see Multimedia Appendix 1).
Intervention Characteristics
In most studies, an app was supplemented with other
interventions, such as a website [28,36-39,41], voice telephone
messages [33], exercise prescription [34], a nasal mask and an
auto-titrating machine [35], an electronic medication tray, email,
SMS, or phone call [24-27], and education provided by a nurse
[28]. The control group in the controlled studies had usual care.
In some studies, this was combined with the recording of
prescribed exercise [34] and the BP measurements [42] in a
logbook or with the education provided by a nurse [28].
Functionalities of the Apps
The 21 reviewed studies used 16 apps. Fourteen different apps
were used in 14 studies [28-35,39-44], 1 app was used in 3
studies [36-38], and another app was used in the other 4 studies
[24-27].
The main functions of the apps can be categorized into the
strategies involved: self-monitoring capabilities, goal setting,
the reminder and alert component (the use of prompts or cues),
automatic feedback, educational information, communication
with HCPs and stress management. All 16 apps incorporated at
least one of these functions. Table 1 summarizes the
characteristics of the apps and systems.
The 16 apps have some similar characteristics and
functionalities. All the apps have self-monitoring capabilities
for BP and other health data (medication adherence, physical
activity, eating and drinking, weight, sleep, stress, symptoms,
medication side effect, and self-reflection answers) [24-44].
This enables the user to track their BP and other health data
over time in different formats, including graphical and/or tabular
formats, and access the summary, raw data and/or analyzed
results, the majority of which consisted of the BP, medication
adherence, physical activity, eating and drinking, weight, and
stress. The second most common functionality was a reminder
and alert component that prompts self-monitoring by reminding
patients about their medication time, BP measurements, hospital
visits or personal goals, or the system alerts another person (eg,
health professional) when a medication dose is missed or when
the BP is higher than the normal level, a feature included in
13/16 (81%) apps [24-29,31-34,36-42,44].
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 7 | e10723 | p.4http://mhealth.jmir.org/2018/7/e10723/
(page number not for citation purposes)
Alessa et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX









—✔✔✔✔✔Anglada-Marti囲nez et al [39]
—✔——✔✔Bengtsson et al [36]
—✔——✔✔Bengtsson et al [37]
—✔——✔✔Hallberg et al [38]
—✔✔✔✔✔Carrera et al [40]
—✔——✔✔McGillicuddy et al [25]
—✔——✔✔McGillicuddy et al [26]
—✔——✔✔Davidson et al [24]
—✔——✔✔McGillicuddy et al [27]
—✔✔✔✔✔Bloss et al [28]
———✔✔✔Patel et al [29]
—✔—✔✔✔Or and Tao [42]
—✔——✔✔Logan et al [33]
————✔✔Petrella et al [34]
———✔✔✔Albini et al [41]
——✔✔✔✔Mao et al [31]
—✔✔——✔Moore et al [30]
———✔—✔Mendelson et al [35]
—✔—✔✔✔Kang et al [44]
—————✔Sun et al [43]
✔✔✔—✔✔Banerjee et al [32]
Educational information [28,29,31,35,39-42,44] and automatic
feedback [24-28,30,32,33,36-40,42,44] were the next most
common features. Of 16 apps, 6 (38%) apps provided a tool for
the users to communicate with their families and HCPs
[28,30-32,39,40] and 1 app (6%) supported stress management
[32]. Although setting goals is one of the most important
techniques in the self-management of hypertension [45], most
included studies reported that goals were set through negotiation
and discussion between the patients and their HCPs without
explicitly mentioning setting them in the app
[24-27,29-31,34-38,42].
The most common comprehensive combination of strategies
was self-monitoring, educational information, automatic
feedback, reminders, and alerts. This combination was found
in 5/16 (31%) apps [28,39,40,42,44], 3 of which also provided
communication with HCPs [28,39,40], and patients families
[28]. The second most frequently used combination was
self-monitoring and prompt or cue, with the addition of either
feedback [24-27,32,33,36-38] or educational information
[29,31,41], with 2/7 (29%) apps providing communication with
HCPs [31,32]. The remaining 4/16 (25%) apps only focused on
self-monitoring [30,34,35,43] with either educational
information [35], automatic feedback and communication with
HCPs [30] or reminders or alerts [34] (see Table 2).
Regarding the automatic feedback feature, feedback was
provided to participants using different approaches, either active
feedback through self-care messages [33,40,44] and
reinforcement messages [24-27], and passive feedback by
representing data in different color codes to indicate whether
measurement levels deviated from the normal range
[28,32,40,42]. The communication with HCPs was through text
messaging chats in the apps [30-32,39,40], with 1 of these 5
apps (20%) [31] adding consultations via video chats or calls
in the app.
Data Input Methods
Most apps (14/16, 88%) used self-monitoring of BP and
supported other self-monitoring tasks [24-28,30-38,40-44],
while 2 apps (13%) focused solely on self-monitoring of
medication compliance [29,39]. In 50% (7/14) of the apps, the
collected BP readings were transmitted automatically from BP
monitoring devices to the app using wireless transmission. In
3 of these 7 apps (42.9%), Bluetooth was employed
[24-27,33,34] while for the remaining 4 apps (57%) the
transmission method was not described [28,30,35,42]. Manual
entry of BP data was used in 50% of apps (7/14)
[31,32,36-38,40,41,43,44], one of which (14%) also
automatically transmitted data [31].
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Table 2. Common combinations of app functionalities (N=16).
n (%)Common Combination
5 (31)Self-monitoring + automatic feedback + prompt or cue (reminders and alerts) + educational information
4 (25)Self-monitoring + prompt or cue (reminders and alerts) + automatic feedback
3 (19)Self-monitoring + prompt or cue (reminders and alerts) + educational information
1 (6)Self-monitoring + communicate with health professional + automatic feedback
1 (6)Self-monitoring + prompt or cue (reminder and alerts)
1 (6)Self-monitoring + educational information
1 (6)Self-monitoring
Blood glucose readings were also wirelessly transmitted in 3
of the 16 apps (19%) [28,34,42] and medication data was
wirelessly transmitted in 2 of the apps (13%) [24-27,30]. There
was no description of the technology used. Data was inputted
manually in 3 other apps (3/16, 19%) using different formats,
such as choosing an option or typing [29,39,44]. Other manually
inputted data include: weight in 4 apps (25%) [31,32,34,41],
number of steps walked in two apps (13%) [31,34], reflective
answers representing users’ expectations toward their BP
readings in one app [43], answers to questions about well-being,
side effects, symptoms, and medication in another app [44], and
other lifestyle aspects such as smoking, stress, and exercise in
2 apps [32,44].
Quality Appraisal
All 9 RCT studies presented some degree of potential bias when
assessed using the Cochrane Collaboration’s Risk of Bias Tool.
Three of them were of low to moderate risk of bias (fair-good
quality) because they met most of the criteria [33,35,42], while
the remaining studies were considered to be of high risk of bias
(poor quality) [24,25,27,28,30,34] (see Multimedia Appendix
4). Four of the 9 studies (44%) failed to report and apply random
sequence generation [24,25,27,28]. Seven of the 9 studies (78%)
presented a high risk of bias or information was not explicitly
provided regarding the blinding of participants, personnel, or
the outcome assessor [24,28,30,33-35,42]. Five (5/9, 56%)
studies had a high risk of bias in other areas, such as small
sample size [24,25,27,30,42].
One controlled study presented poor quality because of failure
to apply blinding of the outcome assessor and sample size
justification (see Multimedia Appendix 5). Most observational
studies (4/7, 57%) were found to be of poor quality because of
a high risk of bias or the lack of information concerning the
sampling method and selection [32,39,43,44], and failure to
clearly report the study aims, design, duration, and outcome
measures [32,40], as well as high attrition rate [39,44]. The
remaining 3 (43%) studies were of fair-good quality [26,31,37]
(see Multimedia Appendix 6). One of the pre-post studies (1/2,
50%) presented poor quality because of selection and attrition
bias [39] (see Multimedia Appendix 7). The two qualitative
studies were deemed to be of low risk of bias as they met most
of the CASP tool’s criteria. However, both seemed to fail to
adequately report the saturation of data during data collection
and the relationship between researcher and participants (see
Multimedia Appendix 8).
Blood Pressure
Fourteen studies (14/21, 67%) reported outcomes related to BP
[24,25,27-31,33-35,37,39,41,42]. From these, 9 studies (64%)
were RCTs [24,25,27,28,30,33,34,35,42], and 5 (36%) were
nonrandomized studies [29,31,37,39,41]. Only 2 (14%) of them
did not report the effect on DBP [25,31]. BP outcomes were
presented as mean [25,27,29,39], mean change [24,28,30,33,37],
or both [31,34,41,42] (see Multimedia Appendix 3).
As shown in Table 3, 6/9 (67%) studies demonstrated positive
effects on BP [24,25,27,30,33,42], whereas 3/9 (33%) studies
reported no positive impact on BP [28,34,35]. The 6 studies
that demonstrated positive effects showed a significant decrease
in SBP (P<.05). The decrease in the intervention arm ranged
from 8.7 to 34.8 mm Hg [24,25,27,30,33,42]. Significant
decreases in DBP were reported in 2/6 (33%) studies, ranging
from 4.9 to 12 mm Hg [24,33]. Only 1 of the 6 studies (17%)
[30] reported a nonsignificant trend toward greater decrease.
Three out of 9 studies (33%) were of fair-good quality. However,
the remaining 6 studies (67%) were of poor quality (see Quality
Appraisal section for an in-depth discussion of this). Of the 3
studies that were fair-good quality, only 2 (67%) were positive.
Five of the studies (5/14, 36%) are nonrandomized
[29,31,37,39,41]. Of these, 4 (80%) reported a significant
decrease in BP [29,31,37,41]. This decline ranged from 5.7 to
10.5 mm Hg and from 4.9 to 6.2 mm Hg for SBP and DBP
respectively (see Table 4). Three of the 5 (60%) nonrandomized
were of good-fair quality and 2 (40%) of the studies were of
poor quality (see Quality Appraisal section).
Of the 6 studies with low-moderate risk of bias, 1 (17%) reported
no significant effect on BP [18]. Five studies, 2 of which were
RCTs (40%) [33,42] that reported positive impacts on BP. Most
of these studies (4/5, 80%) used apps with functionalities
including self-monitoring as well as reminders and alerts with
either automatic feedback [33,37] or educational information
[29,31], while 1 RCT used the most comprehensive combination
of strategies including self-monitoring, reminders and/or alerts,
automatic feedback and educational information [42]. Two other
studies (2/14, 14%) [28,39] using apps with the same
comprehensive combination of functionalities represented a
high risk of bias and reported no statistically significant effects
of using the app.
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Table 3. Blood pressure effects and quality of randomized controlled trial (RCT).




Logan et al [33], mean (SD)
Intervention
Positive–4.2 (9.3)Positivea–8.7 (14.7)5512Over 24 hours
Positive–4.6 (9.2)Positivea–9.1 (15.6)5512During the daytime
Control
—–1.1 (6.8)—–1.7 (12.1)5512Over 24 hours
—–1.3 (6.6)—–1.5 (12.2)5512During the daytime
Or and Tao [42], mean (95% CI)
Neutralb–8.0 (–11.5 to –4.5)Positive–16.7 (–22.8 to –10.7)333Intervention
—–2.1 (–8.6 to 4.4)c—–2.1 (–8.6 to 4.4)303Control
Mendelson et al [35]
NeutralNRNeutralNRd544Intervention
—NR—NR534Control
Davidson et al [24], mean
Positive–12Positive–34.8336Intervention
—–4.5—–9.7306Control
McGillicuddy et al [25] (mm Hg), mean (SE)
NRNRPositive132.2 (3.7)912Intervention
——154.2 (5.7)912Control
McGillicuddy et al [27] (mm Hg), mean
Neutral80.70Positive121.8093Intervention
—79.44—138.78103Control
Moore et al [30], mean (SD)
Neutral–13.7 (9.4)Positive–26.3 (11.9)203Intervention
—–8.2 (8.6)—–16.0 (12.1)223Control
Petrella et al [34]
NeutralNRNeutralNR7513Intervention
—NR—NR7413Control
Bloss et al [28], mean
Neutral–3.6NeutralNR656Intervention
—–6.1—NR656Control
aThe app had significant positive effect on blood pressure.
bThe app had neutral effect on blood pressure.
cP<.001.
dNR: not reported.
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Table 4. Blood pressure effects and quality of nonrandomized studies.
Diastolic Blood PressureSystolic Blood PressureNFollow up
point, month
Randomized controlled trial study
EffectChangeEffectChange
Bengtsson et al [37], mean (SD)
Positive–4.9 (10)Positivea–7 (18)502Intervention
—NR—NRb502Control
Patel et al [29] (mm Hg), mean
Positive85Positive135507Intervention
—NR—NR307Control
Mao et al [31], mean (SE)
NRNRPositive–5.96 (1.64)7634Intervention
—NR—NR734Control
Albini et al [41], mean (SD)
Positive–6.2 (3.8)Positive–10.5 (6.3)3036Intervention
—–3.4 (4.5)—–6.1 (6.9)2986Control
Anglada-Martínez et al [39] (mm Hg), mean (SD)
Neutral75.4 (6.7)Neutralc131.3 (9.8)426Intervention
—79.9 (9.6)—130.2 (13.9)426Control
aThe app had significantly positive effect on blood pressure.
bNR: not reported.
cThe app had neutral effect on blood pressure.
The evidence is therefore inconclusive about which of these
functionality combinations would be more effective in lowering
BP, but it suggests that apps incorporating more comprehensive
functionalities are likely to be effective.
Usability, Satisfaction, and Attitudes
Two of the 21 studies (10%) explored the usability of the apps
[36,40] and 9 (43%) assessed user satisfaction with and attitudes
toward the apps [26,27,30-32,38,39,43,44], 1 of which (1/9,
11%) also evaluate usability among experts [44]. All of these
11 studies focused on the patient perspective, whereas 5 of them
(46%) also considered the HCPs’ perspective [30,36,39,40,44].
Generally, the use of the app was highly accepted by participants
in all 9 studies that assessed user satisfaction
[26,27,30-32,38,39,43,44]. User satisfaction was measured
through the participants rating their experience with the app
[30,31], administration of satisfaction questionnaires
[26,27,32,39,44], or conducting interviews [38,43]. The
satisfaction rate ranged from 7.2 to 9.8 [30,31,39] for studies
using a 10-point satisfaction rating scale, and from 3.1 to 4.8
[27,44] for studies utilizing a 5-point satisfaction rating scale.
The participants reported that the apps were easy to use
[27,32,38,39,43], convenient [38,43], helpful in effectively
communicating with HCPs [26,27] and in hypertension
management [27,38,43,44], including medication adherence
and adjustment [26,27,43], and helped increase their active role
in care, health awareness, and motivation [30,38,43]. Although
some participants felt that the apps were useful only for patients
with an unstable BP [38,43], elderly patients, patients with
polypharmacy or caregivers [39], most patients and HCPs stated
that they would continue using the app after the study [30,39,43]
and would recommend it to their friends [39]. In 3 of the 9
studies (33%) [30,38,43] the participants suggested that the app
would be more useful if improvements could be made. These
improvements include tailoring the graph according to the
participants’ preference, for example, coloring graphs, sending
motivational messages according to the inputted data [38]. It
also was suggested to support the self-monitoring of other
conditions such as blood glucose [43], include alerts that inform
patients if the BP readings are abnormal, and improving the
performance of the app by loading faster [30].
One study (1/3, 33%) evaluated the app through conducting
heuristic evaluation among technology and health informatics
experts, and 2 studies (2/3, 67%) only conducted a usability test
of the app amongst users. In the heuristic evaluation, some
usability problems were identified. Of the 2 studies that assessed
usability among users, 1 used direct observation of the
participants [40] and the other used an observation method with
specific questions asked to the participants [36]. All the
participants found both apps easy to use [36,40].
Six studies assessing usability and satisfaction (6/11, 55%) were
of poor quality and only 5 of the 11 (46%) presented a
low-moderate risk of bias. Generally, the participants seemed
satisfied with the apps, they accepted using them in managing
their condition and found them easy to use.
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The aim of this systematic review was to synthesize evidence
about the effectiveness, acceptance, and usability of using
mobile and tablet apps to reduce BP.
This review found studies about 16 apps with similar
functionalities. However, they were different in the number of
combined functionalities. The majority of the apps used different
combinations of functionalities, whereas 1 app had only 1
function [43]. In all 9 studies that assessed users’ satisfaction,
the participants generally seemed to accept using apps to support
the self-management of their BP. It also indicates that using the
apps seems to be effective in supporting the self-management
of hypertension and has the potential to lower BP as this was
reported in 10 studies (6 RCTs and 4 nonrandomized studies).
It should be noted that, of these, only 2 RCTs (33%) and 3
nonrandomized studies (75%) were of good quality. Due to the
variety of study designs and quality the results, there is
inconclusive evidence about which of these functionality
combinations would be more effective in lowering BP. However,
it would appear that apps incorporating more comprehensive
functionalities are likely to be effective.
This study found that using apps may help reduce SBP and DBP
significantly. Notably, this result was in accordance with other
studies using mobile and other similar older technologies
[11,46]. In 1 meta-analysis, a decrease of 5 mm Hg in DBP or
10 mm Hg in SBP was found to reduce coronary heart disease
events by 22% and stroke by 41% [47], as a decrease of 1 mm
Hg in SBP leads to a 5% reduction in the risk of stroke [46].
The findings of this review are in line with other systematic
reviews that involved mobile phone and tablet-based
intervention in managing chronic diseases, which showed that
the use of apps has the potential to improve health outcomes
among those living with chronic diseases [8,10,11,48,49].
The results with regard to acceptance are supported by studies
assessing the acceptance and usability of mobile apps in the
management of chronic diseases [49,50]. A study assessing the
usability of a commercially available app for diabetes found a
lack of usability for its main target users of elderly diabetics
[51]. This finding, thereby, highlights the importance of
assessing the usability of apps for hypertension and close
cooperation and intensive usability tests with the targeted users
during the development process of the apps.
In some studies, the apps were used in combination with other
platforms, such as a website. The reported effects, therefore,
cannot be solely attributed to the apps. The use of apps with
automatic feedback without the involvement of clinicians to
monitor patients remotely may be effective in controlling BP.
Similarly, apps in which HCPs were involved in monitoring
patients remotely and providing their feedback or instructions,
with either automatic feedback or not, could also have a
significant impact on BP. In short, it is possible that both
approaches are effective.
The results of this review should be interpreted with caution,
as some studies with a high risk of bias (6/9, 67% of RCTs;
6/10, 60% of nonrandomized studies) were included, and
methodological issues have been identified in most of the
included studies. These issues emerged from potential biases
in some RCT studies because of the failure to implement the
blinding of subjects and the assessor, lack of concealment and
randomization procedures, small sample size, and short study
duration. However, the blinding of subjects was impossible
across the interventions due to the nature of using apps.
Nonrandomized quantitative studies also had limitations, such
as their small sample size, short duration, and attrition bias [39].
Many of the studies included in this paper were conducted in
different health and social care settings, which means that
comparisons between them are not straightforward.
Consequently, the generalizability of the results of some of these
studies is limited. Although evidence of the effectiveness of
mHealth is increasing, there is a lack of evidence concerning
the sustainability of the findings after the app intervention has
ceased. This suggests that further research is warranted to
determine long-term benefits and eliminate these limitations.
Strengths and Limitations of this Review
This review has some limitations that should be considered
when interpreting the results. First, studies published in
languages other than English were not included, which increases
the likelihood of relevant research being missed. Moreover, all
types of studies were included regardless of their quality as it
is often helpful to have more recent findings. However,
low-quality studies present more inconclusive data, which affects
the results. It was not possible to conduct a meta-analysis due
to the study designs heterogeneity; combining results that have
been obtained from different types of randomized and
nonrandomized studies will not yield useful data. In addition,
the inclusion of controlled and non-controlled studies might
yield a combination of possibly inconclusive results. Their
inclusion may offer a wider body of evidence. Despite these
limitations, this study is the first systematic review exploring
the effectiveness of using mobile apps in the self-management
of hypertension and their acceptance among users.
Consequently, it might be a useful roadmap to guide further
studies on the use of mobile apps by people with hypertension.
The authors developed a comprehensive search strategy and
then hand searched the reference lists of each identified full-text
articles and systematic review to find potentially relevant studies
for inclusion in this systemic review and considered
combinations of functionalities that were used in the apps.
Recommendations for Further Study
The methodological quality of studies included in this review
was generally low. This indicates that future studies should
consider some essential criteria, including a sufficient number
of participants and duration time, concealment and
randomization procedures, blinding of the assessor, and low
attrition rates. Future studies assessing the effectiveness of apps
should focus on apps that incorporate more comprehensive
functionalities, that are identified in this review as the most
promising functionalities for self-management of hypertension,
including self-monitoring, reminders and alerts with either
automatic feedback or educational information or both. It is
important also to assess and understand users’ satisfaction with
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and acceptance of these apps. A well-designed RCT with
multiple arms using apps with different combinations of
functionalities to enable identification of the most effective
combinations would also be beneficial.
Conclusion
This systematic review indicates that the use of apps to support
the self-management of hypertension are accepted by patients
and could assist in lowering and controlling their BP. It would
appear that apps incorporating more comprehensive
functionalities are likely to be effective. The results should be
interpreted with caution, as most of the studies were of high
risk of bias. More research is required to identify the
effectiveness of using apps in lowering BP and to understand
what functionality combinations are effective for lowering BP.
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CASP: Critical Appraisal Skills Programme
DBP: diastolic blood pressure
HCP: health care professional
mHealth: mobile health
SBP: systolic blood pressure
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